Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
230962 participants
INTERVENTIONAL
2022-08-18
2023-04-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
NCT05493787
Personalized Nudging to Increase Influenza Vaccinations
NCT06566534
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
NCT04565353
High-risk Influenza Vaccine Alert
NCT05492786
The Effect of Time-Slot Scheduling on Flu Vaccination Rates
NCT01206686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible patients will be randomized to either receive or not receive a one-item, pre-visit questionnaire about the flu shot (that will show responses to clinicians in an existing flu shot alert).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Passive Control
No change to the standard of care for flu vaccines
No interventions assigned to this group
Pre-visit Questionnaire
One-item questionnaire in online patient portal and additional information in the flu shot alert
Precommitment Nudge
Ask participants to commit to a decision about getting a flu shot
Salience
Additional text and icon in the flu shot alert makes the pre-visit questionnaire response salient to the clinician, which could facilitate action or further discussion with the patient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Precommitment Nudge
Ask participants to commit to a decision about getting a flu shot
Salience
Additional text and icon in the flu shot alert makes the pre-visit questionnaire response salient to the clinician, which could facilitate action or further discussion with the patient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has an upcoming flu shot-eligible outpatient visit with a provider
* Has activated Geisinger's patient portal
* Has not yet received a flu vaccine at the time the questionnaire became available, according to the EHR
* Any Geisinger clinician who sees patient-participants in our study for a flu shot-eligible outpatient visit
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher F Chabris, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher F Chabris, PhD
Role: PRINCIPAL_INVESTIGATOR
Geisinger Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geisinger Clinic
Danville, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0419
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.